Three-day quinine-clindamycin treatment of uncomplicated falciparum malaria imported from the tropics [1]

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 1173-

  Adehossi, Eric ^a   Parola, Philippe ^a   Foucault, Cedric ^a   Delmont, Jean ^a   Brouqui, Philippe ^a   Badiaga, Sekene ^a   Ranque, Stephane ^b  

^a HÔPITAL NORD   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; MEFLOQUINE; QUININE;

ANXIETY; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOLERANCE; HUMAN; HYPOACUSIS; HYPOGLYCEMIA; LETTER; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RASH; SIDE EFFECT; TIME SERIES ANALYSIS;

AFRICA; ANTI-BACTERIAL AGENTS; ANTIMALARIALS; CLINDAMYCIN; DRUG THERAPY, COMBINATION; HUMANS; INJECTIONS, INTRAVENOUS; MALARIA, FALCIPARUM; QUININE; TREATMENT OUTCOME;

EID: 0037417072     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.1173.2003     Document Type: Letter

References (1)

1. Parola, P., S. Ranque, S. Badiaga, M. Niang, O. Blin, J.-J. Charbit, J. Delmont, and P. Brouqui. 2001. Controlled trial of 3-day quinine-clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics. Antimicrob. Agents Chemother. 45:932-935.